Developing Global Value Dossiers (GVDs) is one of the most complex and time-consuming steps in the market access process. Medical Affairs, HEOR, and Regulatory teams must synthesize large volumes of clinical, economic, and real-world evidence while meeting the requirements of multiple HTA bodies across global markets. MadeAi delivers AI-powered GVD automation designed for life…

In highly regulated life sciences environments, AI adoption is often delayed due to compliance, data security, and ownership concerns. MadeAi addresses these challenges by delivering compliant, auditable AI solutions through a structured Build–Operate–Transfer approach that ensures long-term ownership and control. The Build–Operate–Transfer (BOT) model supports phased AI adoption by collaboratively developing compliant solutions and validating…

Accuracy and methodological rigor define the credibility of GenAI-based literature review systems. MadeAi-LR establishes a measurable framework for assessing AI reliability, minimizing hallucinations, and ensuring scientifically validated outcomes across every stage of evidence synthesis. Download Accuracy in GenAI-Based Literature Review Systems to discover the metrics, methodologies, and best practices shaping the next generation of trustworthy…

Traditional literature reviews are slow, expensive, and resource-heavy. MadeAi™ makes literature reviews fast and efficient with MadeAi-LR. MadeAi-LR harnesses GenAI to streamline evidence synthesis, accelerating timelines while maintaining rigor and transparency. With both self-service and full-service options, MadeAi-LR helps life sciences teams cut workload, reduce costs, and deliver high-quality results faster. Download Unlock the ROI…